Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States.
Gossamer Bio stock last closed at $1.24, down 2.36% from the previous day, and has increased 139.85% in one year. It has overperformed other stocks in the Biotechnology industry by 2.16 percentage points. Gossamer Bio stock is currently +138.46% from its 52-week low of $0.52, and -20% from its 52-week high of $1.55.
As of Jun 13, 2025, there are 227.3M shares of GOSS outstanding. The market cap of GOSS is $281.85M. In the last 24 hours, 1.13M GOSS shares were traded.
You need an online brokerage account to access the NASDAQ market and buy GOSS shares.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal information so you are able to invest in GOSS today.
Now that you have created your account on apps for stocks, you need to deposit funds:
Check out this video walkthrough if you need help depositing funds into your brokerage account.
After you have figured out the best place to buy Gossamer Bio stock, it's critical to analyze their stock before you invest, so you truly wrap your head around the risk and upside.
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on GOSS's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge GOSS's true value.
You can access more valuation research on GOSS's stock here.
Out of 3 Wall Street analysts who give ratings on GOSS, the consensus analyst rating on Gossamer Bio is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Gossamer Bio stock forecast page.
In the last year, insiders at GOSS have bought more shares than they have sold.
Richard Aranda, Chief Medical Officer of GOSS, was the latest GOSS insider to sell. They sold $1,259.28 worth of GOSS shares on Jun 24, 2024.
Get more info about who owns GOSS shares here.
No, Gossamer Bio doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary types of orders:
Hit the Open button and eToro will place your order.
If you want more help buying stocks on eToro, watch the how to video below:
Now that you own some GOSS stock, you'll want to keep up with your new company.
Make a watchlist to track the most important metrics related to your GOSS stock.
To summarize, here are the 6 steps to buy stock in Gossamer Bio:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Gossamer Bio, hit the button below to create your watchlist.